International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP)&#xa0;definition

RECOMMENDED

Further Publications

The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)

★ 1 Recommended by Dr. med. Martin Frey, Faculty Member

J Heart Lung Transplant

Irving C, Azeka E, Adorisio R, Blume ED, Bogle C, Chubb H, Conway J, Cousino MK, Edelson J, Ford K, Holinski P, Janousek J, Lal A, Lee T, Lorts A, Nakano S, Rosenthal DN, Rossano J, Miyamoto SD

doi: 10.1016/j.healun.2025.06.003

Further Publications

Authors Insights on the Updated International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)

J Heart Lung Transplant

Miyamoto SD, Irving C, Azeka E, Adorisio R, Blume ED, Bogle C, Chubb H, Conway J, Cousino MK, Edelson J, Ford K, Holinski P, Janousek J, Lal A, Lee T, Lorts A, Nakano S, Rosenthal DN, Rossano J

doi: 10.1016/j.healun.2025.06.004

Interstitial Lung DiseaseFurther Publications

The importance of considering progression speed in systemic sclerosis-associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study

Respir Res

Roeser A, Brillet PY, Tran Ba S, Caux F, Dhote R, Nunes H, Uzunhan Y

doi: 10.1186/s12931-025-03375-7

Interstitial Lung Disease

From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation

J Heart Lung Transplant

Farrand E, Wolters PJ, Garcia CK, Newton CA

doi: 10.1016/j.healun.2026.06.012

COMMENTED

Interstitial Lung Disease

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)

★ 3 Recommended by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Eur Respir J

Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM

doi: 10.1183/13993003.02533-2024

RECOMMENDED

Lung Cancer

Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Dingemans AC, Opitz I, Brunelli A, Remon J, Hendriks LEL, Edwards J, Faivre-Finn C, Reguart N, Smit EF, Levy A, Sanchez-Lorente D, Trujillo JC, Filippi AR, Stathopoulos K, Blum TG, Guckenberger M, Popat S, De Angelis R, Hofman P, von der Thüsen J, Hartemink KJ, Petersen RH, Ruffini E, Dickhoff C, Houda I, Prisciandaro E, De Ruysscher D, Derks J, Bahce I, Mariolo A, Besse B, Xenophontos E, Giaj Levra N, van Schil P, Brandão M, Berghmans T

doi: 10.1016/S2213-2600(26)00051-2

RECOMMENDED

Lung Cancer

Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group

★ 2 Recommended by Dr. med. Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lung Cancer

Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De la Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T

doi: 10.1016/j.lungcan.2025.108671

COMMENTED

Lung Cancer

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer

★ 3 Recommended and commented by Dr. med. Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Eur Respir J

Brunelli A, Hardavella G, Huber RM, Berghmans T, Frille A, Rodriguez M, Tietzova I, Depypere L, Asteggiano R, Batchelor T, Costantini A, De Ruysscher D, Durieux V, Faivre-Finn C, Ferguson MK, Langer D, Marczin N, Nagavci B, Novoa N, Pompili C, Rawlinson J, Snoeckx A, Tonia T, van Geffen WH, Williams C, Caruana EJ, Kabalak PA, Mansmann U, Fallet V, Kauffmann-Guerrero D, Paesmans M, Al Tawil A, Alhannoush N, Creamer AW, Kourouni I, Blum TG

doi: 10.1183/13993003.00156-2025

Pulmonary Hypertension

Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease

Chest

Garcia AR, Vollmer I, Blanco I, San José Estepar R, Rodriguez-Chiaradía DA, López-Meseguer M, Martin-Ontiyuelo C, Nardelli P, Hernandez-Gonzalez F, Bosacoma A, Ribas J, Pomares X, Santos S, Molina-Molina M, Sellares J, Rahaghi FN, Washko G, San José Estepar R, Barberà JA

doi: 10.1016/j.chest.2026.05.027

Pneumology

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition

Related content

The International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)

Authors Insights on the Updated International Society for Heart and Lung Transplantation Guidelines for the Management of Pediatric Heart Failure (Update From 2014)

The importance of considering progression speed in systemic sclerosis-associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study

From Guideline to Practice: Operationalizing Telomere Length Testing in ILD and Lung Transplantation

Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration

Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group

European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer

Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease